Mode
Text Size
Log in / Sign up

CDC recommends second 2024-2025 COVID-19 vaccine dose for older adults and immunocompromised personsWho should get a second COVID-19 shot this fall? The CDC has new advice

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider CDC recommendation for a second 2024-2025 COVID-19 vaccine dose in older adults and immunocompromised persons.

The Centers for Disease Control and Prevention (CDC) has issued a public health recommendation for specific populations in the United States. The recommendation applies to adults aged 65 years and older and persons aged 6 months and older with moderate or severe immunocompromise. The guidance advises that these groups receive a second dose of the 2024-2025 COVID-19 vaccine formulation, with a suggested interval of 6 months after their last dose.

This is not a research study, and no clinical trial data, efficacy results, or safety outcomes are reported. The sample size, study design, comparator, follow-up duration, and specific outcomes are not provided. The recommendation is based on public health considerations, but the underlying evidence review is not detailed in this report.

No safety or tolerability data for this specific dosing schedule are presented. Adverse events, serious adverse events, and discontinuation rates are not reported. The key limitation is that this is a policy recommendation document, not a peer-reviewed study of vaccine effectiveness or safety. The rationale, strength of evidence, and potential conflicts of interest are not reported.

For practice, this represents an official CDC update to vaccination guidance for the 2024-2025 season. Clinicians should be aware of this new recommendation for a second dose in these high-risk groups. The clinical relevance is restrained to following updated public health guidance, as patient-specific efficacy and safety data from controlled studies are not available.

If you're 65 or older, or if you have a condition that weakens your immune system, health officials have a new message for you this fall. The Centers for Disease Control and Prevention (CDC) is now recommending that people in these groups get a second dose of the 2024-2025 COVID-19 vaccine. The advice is to get that second shot about six months after your last dose.

This is an official recommendation from the CDC's advisory committee. It's important to understand what this is and what it isn't. This announcement is not the result of a brand-new clinical trial that followed people after they got a second shot. The CDC panel made this call after reviewing the latest data on how immunity can wane, especially in older adults and those who are immunocompromised.

Because this is a recommendation and not a study report, we don't have fresh numbers on how much extra protection a second dose might give, or detailed data on side effects from getting another shot. The advice is based on the principle that these groups are at higher risk for severe COVID-19 and may benefit from an extra layer of protection as time passes. If you fall into one of these groups, it's a good idea to talk with your doctor about timing your next vaccine.

What this means for you:
CDC advises adults 65+ and immunocompromised people to get a second COVID shot this fall.

Study Details

EvidenceLevel 5
PublishedDec 2024
View Original Abstract ↓
This report describes CDC's recommendation that all people aged ≥65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.